Efficacy of an Evernimicin (SCH27899) In Vitro and in an Animal Model of Lyme Disease
收藏PubMed Central2026-05-16 收录
官方服务：
资源简介：
The MICs of evernimicin at which 90% of Borrelia burgdorferi patient isolates were inhibited ranged from 0.1 to 0.5 μg/ml. Evernimicin was as effective as ceftriaxone against B. burgdorferi in a murine model of experimental Lyme disease. As assessed by culturing the urinary bladders of infected C3H mice, no live Borrelia isolates were recoverable following antibiotic treatment.
